Ondansetron, orally disintegrating tablets versus intravenous injection for prevention of intrathecal morphine-induced nausea, vomiting, and pruritus in young males

Anesthesia and Analgesia

Volumn 101, Issue 5, 2005, Pages 1330-1336

  Pirat, Arash ^a   Tuncay, Şenay F ^b   Torgay, Adnan ^b   Candan, Selim ^b   Arslan, Gulnaz ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIPRURITIC AGENT; ATROPINE; BUPIVACAINE; DIPHENHYDRAMINE; DISINTEGRATING AGENT; DROPERIDOL; MORPHINE; ONDANSETRON;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ORALLY DISINTEGRATING TABLET; PAIN ASSESSMENT; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; TABLET FORMULATION; VISUAL ANALOG SCALE;

EID: 27444434341     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000180830.12355.D9     Document Type: Article

References (30)

1. Brill S, Gurman GM, Fisher A. A history of neuraxial administration of local analgesics and opioids. Eur J Anaesthesiol 2003;20:682-9.
2. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;77:162-84.
3. Chaney MA. Side effects of intrathecal and epidural opiates. Can J Anaesth 1995;42:891-903.
4. Kjellberg F, Tramer MR. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 2001;18:346-57.
5. Pan PH, Moore CH. Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesth Analg 1996;83:982-6.
6. Pan PH, Moore CH. Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. J Clin Anesth 2001;13:430-5.
7. Parlow JL, Costache I, Avery N, Turner K. Single-dose haloperidol for the prophylaxis of postoperative nausea and vomiting after intrathecal morphine. Anesth Analg 2004;98:1072-6.
8. Dimitriou V, Voyagis GS. Opioid-induced pruritus: repeated vs single dose ondansetron administration in preventing pruritus after intrathecal morphine. Br J Anaesth 1999;83:822-3.
9. Charuluxananan S, Somboonviboon W, Kyokong O, Nimcharoendee K. Ondansetron for treatment of intrathecal morphine-induced pruritus after cesarean delivery. Reg Anesth Pain Med 2000;25:535-9.
10. Yeh HM, Chen LK, Lin CJ, et al. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesth Analg 2000;91:172-5.
11. LeBourgeois JP, McKenna CJ, Coster B, et al. Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment. Clin Oncol (R Coll Radiol) 1999;11:340-7.
12. Davidson N, Rapoport B, Erikstein B, et al. Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: a multicenter, double-masked study. Ondansetron Orally Disintegrating Tablet Emesis Study Group. Clin Ther 1999;21:492-502.
13. Gan TJ, Franiak R, Reeves J. Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg 2002;94:1199-200.
14. Thagaard KS, Steine S, Raeder J. Ondansetron disintegrating tablets of 8 mg twice a day for 3 days did not reduce the incidence of nausea or vomiting after laparoscopic surgery. Eur J Anaesthesiol 2003;20:153-7.
15. Carr D, Cousins M. Spinal route of analgesia, opioids and future options. In: Bridenbaugh P, ed. Neural blockade in clinical anesthesia and management of pain, 3rd ed. Philadelphia: Lippincott-Raven, 1998:115-83.
16. Koeller JM, Aapro MS, Gralla RJ, et al. Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer 2002;10:519-22.
17. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71.
18. Szarvas S, Chellapuri RS, Harmon DC, et al. A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery. Anesth Analg 2003;97:259-63.
19. Yazigi A, Chalhoub V, Madi-Jebara S, et al. Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine. J Clin Anesth 2002;14:183-6.
20. Pitkanen MT, Numminen MK, Tuominen MK, Rosenberg PH. Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine. Eur J Anaesthesiol 1997;14:172-7.
21. Pitkanen MT, Niemi L, Tuominen MK, Rosenberg PH. Effect of tropisetron, a 5-HT3 receptor antagonist, on analgesia and nausea after intrathecal morphine. Br J Anaesth 1993;71:681-4.
22. Charuluxananan S, Kyokong O, Somboonviboon W, et al. Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesth Analg 2003;96:1789-93.
23. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51.
24. Gurkan Y, Toker K, Prophylactic ondansetron reduces the incidence of intrathecal fentanyl-induced pruritus. Anesth Analg 2002;95:1763-6.
25. Korhonen AM, Valanne JV, Jokela RM, et al. Ondansetron does not prevent pruritus induced by low-dose intrathecal fentanyl. Acta Anaesthesiol Scand 2003;47:1292-7.
26. Borgeat A, Stirnemann HR. Ondansetron is effective to treat spinal or epidural morphine-induced pruritus. Anesthesiology 1999;90:432-6.
27. Arai L, Stayer S, Schwartz R, Dorsey A. The use of ondansetron to treat pruritus associated with intrathecal morphine in two paediatric patients. Paediatr Anaesth 1996;6:337-9.
28. Sanchez-Ledesma MJ, Lopez-Olaondo L, Pueyo FJ et al. A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg 2002;95:1590-5.
29. Roila F, Del Favero A. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet 1995;29:95-109.
30. Rojanasthien N, Manorot M, Kumsorn B. Pharmacokinetics and bioequivalence testing of generic ondansetron preparations in healthy Thai male volunteers. Int J Clin Pharmacol Ther 1999;37:548-54.